{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:35:25Z","timestamp":1783953325533,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.amjmed.2025.10.009","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:30:35Z","timestamp":1760653835000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A new paradigm to reduce cardiovascular disease based on the pathogenesis of atherosclerosis"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-604X","authenticated-orcid":false,"given":"David S.","family":"Schade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Blankenship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Adolphe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Philip","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjmed.2025.10.009_bib0001","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4236\/wjcd.2023.134021","article-title":"COVID-19 and cardiovascular disease \u2013 two pandemics, one success","volume":"13","author":"Eaton","year":"2023","journal-title":"World J Cardiovasc Dis"},{"issue":"24","key":"10.1016\/j.amjmed.2025.10.009_bib0002","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.jacc.2017.10.024","article-title":"Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors","volume":"70","author":"Fern\u00e1ndez-Friera","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2025.10.009_bib0003","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and Validation of the American Heart Association's PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.amjmed.2025.10.009_bib0004","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.2024.12537","article-title":"Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations","volume":"332","author":"Diao","year":"2024","journal-title":"JAMA"},{"issue":"10486","key":"10.1016\/j.amjmed.2025.10.009_bib0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0006","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"B-Libby","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2025.10.009_bib0008","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.119.045256","article-title":"From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents?","volume":"141","author":"Ridker","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2025.10.009_bib0009","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcmg.2021.11.006","article-title":"Coronary artery calcium versus pooled cohort equations score for primary prevention guidance: randomized feasibility trial","volume":"15","author":"Muhlestein","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.amjmed.2025.10.009_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5694\/mja16.01134","article-title":"Cardiac Society of Australia and New Zealand position statement executive summary: coronary artery calcium scoring","volume":"207","author":"Hamilton-Craig","year":"2017","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.amjmed.2025.10.009_bib0011","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"1","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6917","key":"10.1016\/j.amjmed.2025.10.009_bib0012","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.amjmed.2025.10.009_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00019501-200109000-00007","article-title":"Functions of the healthy endothelium","volume":"12","author":"Kharbanda","year":"2001","journal-title":"Coron Artery Dis"},{"issue":"8","key":"10.1016\/j.amjmed.2025.10.009_bib0014","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0024-3205(01)01479-5","article-title":"Experimental atherosclerosis: a historical overview","volume":"70","author":"Moghadasian","year":"2002","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.1978.03290010051023","article-title":"Familial hypobetalipoproteinemia: absence of atherosclerosis in a postmortem study","volume":"240","author":"Kahn","year":"1978","journal-title":"JAMA"},{"issue":"9493","key":"10.1016\/j.amjmed.2025.10.009_bib0016","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"and the Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2025.10.009_bib0017","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0018","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2019.03.005","article-title":"Coronary atheroma regression and adverse cardiac events: a systematic review and meta-regression analysis","volume":"284","author":"Bhindi","year":"2019","journal-title":"Atherosclerosis"},{"issue":"21","key":"10.1016\/j.amjmed.2025.10.009_bib0019","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2005.04.004","article-title":"Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women","volume":"184","author":"Michos","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.100992","article-title":"Performance of PREVENT equations for cardiovascular risk prediction in young patients with myocardial infarction: From the MGB YOUNG-MI registry","volume":"22","author":"Singh","year":"2025","journal-title":"Am J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2025.10.009_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"7855","key":"10.1016\/j.amjmed.2025.10.009_bib0023","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4236\/wjcd.2022.121002","article-title":"Prevention of coronary heart disease: a translational clinical challenge","volume":"12","author":"Giannini","year":"2022","journal-title":"World J Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.amjmed.2025.10.009_bib0025","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.eprac.2024.03.007","article-title":"New insights into the importance of dietary cholesterol in preventing cardiovascular disease","volume":"30","author":"Schade","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221100107","article-title":"A comprehensive review of PCSK9 inhibitors","volume":"27","author":"Coppinger","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjmed.2025.10.009_bib0027","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1753-0407.2012.00212.x","article-title":"Coronary artery calcium scanning in asymptomatic patients with diabetes mellitus: a paradigm shift","volume":"4","author":"Hecht","year":"2012","journal-title":"J Diabetes"},{"issue":"10384","key":"10.1016\/j.amjmed.2025.10.009_bib0028","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0029","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2018.07.014","article-title":"Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions","volume":"276","author":"Raggi","year":"2018","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.amjmed.2025.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2009.08.088","article-title":"Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the \u201cwarranty period\u201d for remaining normal?","volume":"55","author":"Min","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjmed.2025.10.009_bib0031","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcct.2007.10.001","article-title":"Prognostic significance of zero coronary calcium scores on cardiac computed tomography","volume":"1","author":"Shareghi","year":"2007","journal-title":"J. Cardiovasc Comput Tomogr"},{"issue":"4","key":"10.1016\/j.amjmed.2025.10.009_bib0032","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ahj.2009.08.007","article-title":"Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"158","author":"Budoff","year":"2009","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0033","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4236\/wjcd.2023.131002","article-title":"Improving cardiovascular risk assessment to optimize therapy","volume":"13","author":"Adolphe","year":"2023","journal-title":"World J Cardiovasc Dis"},{"issue":"17","key":"10.1016\/j.amjmed.2025.10.009_bib0034","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2022.5333","article-title":"The potential clinical benefit of lowering lipoprotein (a)","volume":"327","author":"Ference","year":"2022","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.amjmed.2025.10.009_bib0035","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2025.10.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2025.05.035","article-title":"Elevated Lipoprotein (a): a treatment challenge and a practical solution","author":"Schade","year":"2025","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2025.10.009_bib0037","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes: the \u201cvulnerable plaque\u201d and superficial erosion","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.amjmed.2025.10.009_bib0038","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwi228","article-title":"Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women","volume":"162","author":"LaMonte","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.amjmed.2025.10.009_bib0039","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jacc.2020.06.076","article-title":"Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review","volume":"76","author":"Abdelrahman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.amjmed.2025.10.009_bib0040","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4236\/wjcd.2021.1112052","article-title":"Finance policy for public health disease prevention: addressing the number one cause of death in the western world","volume":"11","author":"Eaton","year":"2021","journal-title":"World J Cardiovasc Dis"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325007004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934325007004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:37:46Z","timestamp":1771216666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934325007004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0002934325007004"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.10.009","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new paradigm to reduce cardiovascular disease based on the pathogenesis of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2025.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}